Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Dana-Farber Cancer Institute
Condition: Glioblastoma, Recurrent Glioblastoma
NCT04406272
VB-111 in Surgically Accessible Recurrent/Progressive GBM
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Trial stopped at request of VBL Therapeutics, as they are no longer pursuing their VB-111 development program.